Açıklama

Abdominal pain severity scores measured at baseline and across study visits for participants receiving L. acidophilus DDS-1, B. lactis UABla-12, or placebo, showing progressive improvement in the probiotic groups.

Figure 2

Chart

Source Paper

Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdominal Pain Severity and Symptomology in Irritable Bowel Syndrome: Randomized Controlled Trial.

Nutrients (2020)

PMID: 32019158

DOI: 10.3390/nu12020363

Cite This Figure

![Figure 2: Abdominal pain severity scores measured at baseline and across study visits for participants receiving L. acidophilus DDS-1, B. lactis UABla-12, or placebo, showing progressive improvement in the probiotic groups.]()

> Source: Christopher J Martoni et al. "Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdo." *Nutrients*, 2020. PMID: [32019158](https://pubmed.ncbi.nlm.nih.gov/32019158/)

<figure>
  <img src="" alt="Abdominal pain severity scores measured at baseline and across study visits for participants receiving L. acidophilus DDS-1, B. lactis UABla-12, or placebo, showing progressive improvement in the probiotic groups." />
  <figcaption>Figure 2. Abdominal pain severity scores measured at baseline and across study visits for participants receiving L. acidophilus DDS-1, B. lactis UABla-12, or placebo, showing progressive improvement in the probiotic groups.<br>  Source: Christopher J Martoni et al. "Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdo." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32019158/">32019158</a></figcaption>
</figure>

İlgili Kanıtlar

Lactobacillus acidophilus için Irritable Bowel Syndrome (IBS)

Derece B · 3 çalışma